ES549860A0 - Un procedimiento para preparar aminoacil-ladanos - Google Patents

Un procedimiento para preparar aminoacil-ladanos

Info

Publication number
ES549860A0
ES549860A0 ES549860A ES549860A ES549860A0 ES 549860 A0 ES549860 A0 ES 549860A0 ES 549860 A ES549860 A ES 549860A ES 549860 A ES549860 A ES 549860A ES 549860 A0 ES549860 A0 ES 549860A0
Authority
ES
Spain
Prior art keywords
ladanos
aminoacil
preparing
procedure
preparing aminoacil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549860A
Other languages
English (en)
Other versions
ES8703460A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES8703460A1 publication Critical patent/ES8703460A1/es
Publication of ES549860A0 publication Critical patent/ES549860A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES549860A 1984-12-14 1985-12-12 Un procedimiento para preparar aminoacil-ladanos Expired ES8703460A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68177984A 1984-12-14 1984-12-14

Publications (2)

Publication Number Publication Date
ES8703460A1 ES8703460A1 (es) 1987-02-16
ES549860A0 true ES549860A0 (es) 1987-02-16

Family

ID=24736768

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549860A Expired ES8703460A1 (es) 1984-12-14 1985-12-12 Un procedimiento para preparar aminoacil-ladanos

Country Status (19)

Country Link
EP (1) EP0191166B1 (es)
JP (1) JPS61145178A (es)
KR (1) KR900007625B1 (es)
AR (1) AR243877A1 (es)
AT (1) ATE60767T1 (es)
AU (2) AU577912B2 (es)
CA (1) CA1307529C (es)
DE (1) DE3581725D1 (es)
DK (1) DK167218B1 (es)
ES (1) ES8703460A1 (es)
FI (1) FI87208C (es)
GR (1) GR852981B (es)
HU (1) HU201043B (es)
IE (1) IE58698B1 (es)
NO (1) NO171064C (es)
NZ (1) NZ214532A (es)
PH (1) PH24599A (es)
PT (1) PT81659B (es)
ZA (1) ZA859556B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678736D1 (de) * 1985-03-01 1991-05-23 Hoechst Roussel Pharma Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
IN163242B (es) 1985-05-03 1988-08-27 Hoechst India
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
JPS6310783A (ja) * 1985-11-15 1988-01-18 Nippon Kayaku Co Ltd 新規フオルスコリン誘導体
US4734513A (en) * 1986-03-31 1988-03-29 Hoechst-Roussel Pharmaceuticals Inc. Method of synthesizing forskolin from 9-deoxyforskolin
US4740522A (en) * 1986-08-28 1988-04-26 Hoechst-Roussel Pharmaceuticals Inc. Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure
US5247097A (en) * 1986-08-28 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Oxolabdanes
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
CA1307530C (en) * 1986-12-29 1992-09-15 Hoechst-Roussel Pharmaceuticals Inc. Carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments
US5302730A (en) * 1987-06-29 1994-04-12 Nippon Kayaku Kk Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US5846992A (en) * 1987-10-08 1998-12-08 Hoechst Marion Roussel, Inc. Synergistic intraocular pressure lowering combinations
US4902696A (en) * 1987-10-08 1990-02-20 Hoechst-Roussel Pharmaceuticals, Inc. Synergistic intraocular pressure lowering combinations
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
US5051132A (en) * 1989-06-15 1991-09-24 Nippon Kayaku Kabushiki Kaisha Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
DE3678736D1 (de) * 1985-03-01 1991-05-23 Hoechst Roussel Pharma Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.

Also Published As

Publication number Publication date
JPS61145178A (ja) 1986-07-02
NO171064B (no) 1992-10-12
AU5131685A (en) 1986-07-17
FI854919A0 (fi) 1985-12-12
NO171064C (no) 1993-01-20
KR860004915A (ko) 1986-07-16
CA1307529C (en) 1992-09-15
IE853160L (en) 1986-06-14
PH24599A (en) 1990-08-17
AR243877A1 (es) 1993-09-30
ES8703460A1 (es) 1987-02-16
IE58698B1 (en) 1993-11-03
EP0191166B1 (en) 1991-02-06
DK578585A (da) 1986-06-15
GR852981B (es) 1986-04-08
FI87208B (fi) 1992-08-31
ZA859556B (en) 1986-08-27
AU577912B2 (en) 1988-10-06
FI87208C (fi) 1992-12-10
EP0191166A2 (en) 1986-08-20
DE3581725D1 (de) 1991-03-14
HU201043B (en) 1990-09-28
NO855026L (no) 1986-06-16
FI854919A7 (fi) 1986-06-15
ATE60767T1 (de) 1991-02-15
EP0191166A3 (en) 1988-03-02
KR900007625B1 (ko) 1990-10-17
DK167218B1 (da) 1993-09-20
AU3813289A (en) 1989-10-26
PT81659B (pt) 1988-04-21
NZ214532A (en) 1989-05-29
PT81659A (en) 1986-01-01
AU620421B2 (en) 1992-02-20
DK578585D0 (da) 1985-12-13
HUT40636A (en) 1987-01-28

Similar Documents

Publication Publication Date Title
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES543192A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES542051A0 (es) Un procedimiento para preparar derivados de benzoilurea
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
ES545386A0 (es) Un procedimiento para preparar un organotitanato
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES544863A0 (es) Un procedimiento para preparar un compuesto de beta-lactama
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES540784A0 (es) Un procedimiento para preparar compuestos relacionados con espergualina
ES545894A0 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES546690A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona
ES544092A0 (es) Un procedimiento para preparar antibiotico l 17392
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa
ES546669A0 (es) Un procedimiento para preparar compuestos relacionados con histargina
ES553983A0 (es) Un procedimiento para preparar compuestos de piridobenzodiazepina
ES541321A0 (es) Procedimiento para preparar un derivado de fenotiazina
AR241134A1 (es) Un procedimiento para preparar w-lactamas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519